Skip to main content

Advertisement

Log in

Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method

  • Paper
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

A second-generation chlorin-based photosensitizer, 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) has shown tremendous therapeutic potential in clinical trials in the treatment of esophageal cancer. Herein, we have developed and validated a bioanalytical method for estimation of HPPH in rat plasma using High Performance Liquid Chromatography (HPLC) with a photo diode array (PDA) detector. The method was applied for carrying out pharmacokinetic study of HPPH. Further pharmacokinetic modeling was carried out to understand the compartment kinetics of HPPH. The developed method was fully validated as per the United States Food and Drug Administration (US-FDA) guidelines for bioanalytical method validation. The linearity of the method was in the range of 250–8000 ng mL−1, and the plasma recovery was found to be 70%. Pharmacokinetic parameters were evaluated and compared via non-compartment analysis and compartment modeling after the intravenous (i.v.) bolus administration in rats using Phoenix WinNonlin 8.0 (Certara™, USA). From the obtained results, we hypothesize that the HPPH complies with two compartmental pharmacokinetic model. Furthermore, it was observed that HPPH has the rapid distribution from the central compartment to peripheral compartment along with slow elimination from peripheral compartment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D. W. Felsher, Cancer revoked: oncogenes as therapeutic targets, Nat. Rev. Cancer, 2003, 3, 375.

    Article  CAS  Google Scholar 

  2. D. E. Dolmans, D. Fukumura and R. K. Jain, Photodynamic therapy for cancer, Nat. Rev. Cancer, 2003, 3, 380.

    CAS  Google Scholar 

  3. M. A. M. Capella and L. S. Capella, A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors, J. Biomed. Sci., 2003, 10, 361–366.

    Article  CAS  Google Scholar 

  4. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic therapy, JNCI, J. Natl. Cancer Inst., 1998, 90, 889–905.

    Article  CAS  Google Scholar 

  5. A. B. Ormond and H. S. Freeman, Dye sensitizers for photodynamic therapy, Materials, 2013, 6, 817–840.

    Article  CAS  Google Scholar 

  6. R. K. Pandey, A. B. Sumlin, S. Constantine, M. Aoudia, W. R. Potter, D. A. Bellnier, B. W. Henderson, M. A. Rodgers, K. M. Smith and T. J. Dougherty, Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacy, Photochem. Photobiol., 1996, 64, 194–204.

    Article  CAS  Google Scholar 

  7. R. Shibata, T. Mizoguchi, T. Inazu and H. Tamiaki, Self-aggregation of synthetic zinc chlorophyll derivatives possessing multi-perfluoroalkyl chains in perfluorinated solvents, Photochem. Photobiol. Sci., 2007, 6, 749–757.

    Article  CAS  Google Scholar 

  8. D. A. Bellnier, B. W. Henderson, R. K. Pandey, W. R. Potter and T. J. Dougherty, Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a, J. Photochem. Photobiol., B, 1993, 20, 55–61.

    Article  CAS  Google Scholar 

  9. D. A. Bellnier, W. R. Greco, J. C. Parsons, A. R. Oseroff, A. Kuebler and T. J. Dougherty, An assay for the quantitation of Photofrin in tissues and fluids, Photochem. Photobiol., 1997, 66, 237–244.

    Article  CAS  Google Scholar 

  10. E. Sevick-Muraca, M. Gurfinkel, A. B. Thompson, T. L. Troy, J. S. Reynolds, R. Mayer, D. J. Hawrysz, W. Ralston, B. Muggenberger and K. Nikula, others, Pharmacokinetics of ICG and HPPH-car for detection of normal and tumor tissue using fluorescence, near-infrared continuous wave imaging, in Biomed. Opt. Spectrosc. Diagnostics, 2000, p. MD7.

  11. L. Chen, Q. Xiao, X. Zhang and J. Yang, Establishment and comparison of three novel methods for the determination of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in human serum, J. Pharm. Biomed. Anal., 2016, 121, 13–21.

    Article  CAS  Google Scholar 

  12. C. Su, Y. Liu, Y. He and J. Gu, Analytical methods for investigating in vivo fate of nanoliposomes: A review, J. Pharm. Anal., 2018, 219–225.

  13. K.V Krishna, R.N Saha, G. Singhvi and S.K Dubey, Preclinical pharmacokinetic-pharmacodynamic modelling and biodistribution studies of donepezil hydrochloride by a validated HPLC method, RSC Adv., 2018, 8, 24740–24749.

    Article  CAS  Google Scholar 

  14. J. Lobel, I. J. MacDonald, M. J. Ciesielski, T. Barone, W. R. Potter, J. Pollina, R. J. Plunkett, R. A. Fenstermaker and T. J. Dougherty, 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy, Lasers Surg. Med., 2001, 29, 397–405.

    Article  CAS  Google Scholar 

  15. I. da Costa César, F. H. A. Nogueira and G. A. Pianetti, Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection, J. Pharm. Biomed. Anal., 2008, 48, 951–954.

    Article  Google Scholar 

  16. N. Lindegårdh, A. Annerberg, D. Blessborn, Y. Bergqvist, N. Day and N. J. White, Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma, J. Pharm. Biomed. Anal., 2005, 37, 1081–1088.

    Article  Google Scholar 

  17. S. M. Moosavi, K. Shekar, J. Fraser, M. T. Smith and S. Ghassabian, High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC-MS/MS instrumentation, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2016, 1038, 80–87.

    Article  CAS  Google Scholar 

  18. U.S.D. of Health, H. Services, others, Guidance for industry, bioanalytical method validation, http//www.fda.gov/cder/guidance/index.htm, 2001.

  19. U.S. Food, D. Administration, others, Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics, US Food Drug Adm., 2015.

  20. S.W.G. for Forensic Toxicology, Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology, J. Anal. Toxicol., 2013, 37, 452–474.

    Article  Google Scholar 

  21. K. Yamaoka, T. Nakagawa and T. Uno, Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations, J. Pharmacokinet. Pharmacodyn., 1978, 6, 165–175.

    Article  CAS  Google Scholar 

  22. J.-K. Ho, T.-I. Huo, L.-C. Lin and T.-H. Tsai, Pharmacokinetics of ractopamine and its organ distribution in rats, J. Agric. Food Chem., 2014, 62, 9273–9278.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sunil Kumar Dubey.

Additional information

Electronic supplementary information (ESI) available. See DOI: 10.1039/c8pp00339d

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krishna, K.V., Saha, R.N., Puri, A. et al. Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method. Photochem Photobiol Sci 18, 1056–1063 (2019). https://doi.org/10.1039/c8pp00339d

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/c8pp00339d

Navigation